ArticleJournal for immunotherapy of cancer2023

Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma.

Alex Frias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.